Guardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
01 Fevereiro 2024 - 6:05PM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced it will report financial results for the
fourth quarter and full year 2023 after market close on Thursday,
February 22, 2024. Company management will webcast a corresponding
conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m.
Eastern Time.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.guardanthealth.com. The
webcast will be archived and available for replay after the
event.
About Guardant Health
Guardant Health is a leading precision oncology company focused
on guarding wellness and giving every person more time free from
cancer. Founded in 2012, Guardant is transforming patient care by
providing critical insights into what drives disease through its
advanced blood and tissue tests, real-world data and AI analytics.
Guardant tests help improve outcomes across all stages of care,
including screening to find cancer early, monitoring for recurrence
in early-stage cancer, and helping doctors select the best
treatment for patients with advanced cancer. For more information,
visit guardanthealth.com and follow the company on LinkedIn, X
(Twitter) and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240201204485/en/
Investor Contact: investors@guardanthealth.com
Media Contact: Melissa Marasco press@guardanthealth.com
+1 650-647-3711
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Guardant Health (NASDAQ:GH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024